Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Blandini

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Annals of the New York Academy of Sciences|March 23, 2004
Peripheral markers of apoptosis in Parkinson's disease: the effect of dopaminergic drugsF Blandini, A Mangiagalli, M Cosentino, et al.
Neurogastroenterology and Motility|October 4, 2015
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's diseaseG Levandis, B Balestra, F Siani, et al.
Psychopharmacology|December 16, 2003
DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy)F Fornai, P Lenzi, G Frenzilli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's diseaseF Blandini, A Mangiagalli, E Martignoni, et al.
Neuroscience Letters|October 20, 2009
Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's diseaseF Blandini, B Balestra, G Levandis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 16, 2004
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatmentF Blandini, M Cosentino, A Mangiagalli, et al.
Neuropharmacology|May 21, 2017
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegenerationC Pellegrini, L Antonioli, R Colucci, et al.
Parkinsonism & Related Disorders|May 8, 2025
Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarkerM Avenali, S P Caminiti, M Gegg, et al.
Neurobiology of Aging|January 29, 2010
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's diseaseM T Armentero, E Sinforiani, C Ghezzi, et al.
Pharmacological Research|March 18, 2014
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemiaD Mango, G Barbato, S Piccirilli, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Annals of the New York Academy of Sciences|March 23, 2004
Peripheral markers of apoptosis in Parkinson's disease: the effect of dopaminergic drugsF Blandini, A Mangiagalli, M Cosentino, et al.
Neurogastroenterology and Motility|October 4, 2015
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's diseaseG Levandis, B Balestra, F Siani, et al.
Psychopharmacology|December 16, 2003
DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy)F Fornai, P Lenzi, G Frenzilli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's diseaseF Blandini, A Mangiagalli, E Martignoni, et al.
Neuroscience Letters|October 20, 2009
Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's diseaseF Blandini, B Balestra, G Levandis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 16, 2004
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatmentF Blandini, M Cosentino, A Mangiagalli, et al.
Neuropharmacology|May 21, 2017
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegenerationC Pellegrini, L Antonioli, R Colucci, et al.
Parkinsonism & Related Disorders|May 8, 2025
Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarkerM Avenali, S P Caminiti, M Gegg, et al.
Neurobiology of Aging|January 29, 2010
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's diseaseM T Armentero, E Sinforiani, C Ghezzi, et al.
Pharmacological Research|March 18, 2014
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemiaD Mango, G Barbato, S Piccirilli, et al.
Pageof 6